Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 25833 entries
Sorted by: Best Match Show Resources per page
Climate change water vulnerability and adaptation mechanism in a Himalayan City, Nainital, India.

Environmental science and pollution research international

Chauhan D, Thiyaharajan M, Pandey A, Singh N, Singh V, Sen S, Pandey R.
PMID: 34331647
Environ Sci Pollut Res Int. 2021 Jul 31; doi: 10.1007/s11356-021-15713-5. Epub 2021 Jul 31.

Urban water management is a growing concern in India's rapidly urbanizing cities. Population growth and climatic variability are exuberating the impact on surface and underground water supply. Understanding the causes and the extent of water vulnerability is required for...

Cite
Chauhan D, Thiyaharajan M, Pandey A, et al. Climate change water vulnerability and adaptation mechanism in a Himalayan City, Nainital, India. Environ Sci Pollut Res Int. 2021;doi: 10.1007/s11356-021-15713-5.
Chauhan, D., Thiyaharajan, M., Pandey, A., Singh, N., Singh, V., Sen, S., & Pandey, R. (2021). Climate change water vulnerability and adaptation mechanism in a Himalayan City, Nainital, India. Environmental science and pollution research international, . https://doi.org/10.1007/s11356-021-15713-5
Chauhan, Disha, et al. "Climate change water vulnerability and adaptation mechanism in a Himalayan City, Nainital, India." Environmental science and pollution research international vol. (2021). doi: https://doi.org/10.1007/s11356-021-15713-5
Chauhan D, Thiyaharajan M, Pandey A, Singh N, Singh V, Sen S, Pandey R. Climate change water vulnerability and adaptation mechanism in a Himalayan City, Nainital, India. Environ Sci Pollut Res Int. 2021 Jul 31; doi: 10.1007/s11356-021-15713-5. Epub 2021 Jul 31. PMID: 34331647.
Copy Download .nbib Format: NLM
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.

Nature

Carreño JM, Alshammary H, Tcheou J, Singh G, Raskin A, Kawabata H, Sominsky L, Clark J, Adelsberg DC, Bielak D, Gonzalez-Reiche AS, Dambrauskas N, Vigdorovich V, Srivastava K, Sather DN, Sordillo EM, Bajic G, van Bakel H, Simon V, Krammer F, Newton G.
PMID: 35016197
Nature. 2021 Dec 31; doi: 10.1038/s41586-022-04399-5. Epub 2021 Dec 31.

The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially identified in November of 2021 in South Africa and Botswana as well as in a sample from a traveler from South Africa in Hong Kong

Cite
Carreño JM, Alshammary H, Tcheou J, et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature. 2021;doi: 10.1038/s41586-022-04399-5.
Carreño, J. M., Alshammary, H., Tcheou, J., Singh, G., Raskin, A., Kawabata, H., Sominsky, L., Clark, J., Adelsberg, D. C., Bielak, D., Gonzalez-Reiche, A. S., Dambrauskas, N., Vigdorovich, V., Srivastava, K., Sather, D. N., Sordillo, E. M., Bajic, G., van Bakel, H., Simon, V., Krammer, F., & Newton, G. (2021). Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature, . https://doi.org/10.1038/s41586-022-04399-5
Carreño, Juan Manuel, et al. "Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-022-04399-5
Carreño JM, Alshammary H, Tcheou J, Singh G, Raskin A, Kawabata H, Sominsky L, Clark J, Adelsberg DC, Bielak D, Gonzalez-Reiche AS, Dambrauskas N, Vigdorovich V, Srivastava K, Sather DN, Sordillo EM, Bajic G, van Bakel H, Simon V, Krammer F, Newton G. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature. 2021 Dec 31; doi: 10.1038/s41586-022-04399-5. Epub 2021 Dec 31. PMID: 35016197.
Copy Download .nbib Format: NLM
Beaver Tail Liver: A Hepatic Morphology Variant.

Cureus

Khanduri S, Malik S, Khan N, Singh H, Rehman M.
PMID: 34395114
Cureus. 2021 Jul 12;13(7):e16327. doi: 10.7759/cureus.16327. eCollection 2021 Jul.

Beaver tail liver, or else known as the sliver of liver, is a rare anatomic variation of the liver where the left lobe of the liver extends laterally to contact and enwrap the spleen. A case is presented here...

Cite
Khanduri S, Malik S, Khan N, et al. Beaver Tail Liver: A Hepatic Morphology Variant. Cureus. 2021;13(7):e16327doi: 10.7759/cureus.16327.
Khanduri, S., Malik, S., Khan, N., Singh, H., & Rehman, M. (2021). Beaver Tail Liver: A Hepatic Morphology Variant. Cureus, 13(7), e16327. https://doi.org/10.7759/cureus.16327
Khanduri, Sachin, et al. "Beaver Tail Liver: A Hepatic Morphology Variant." Cureus vol. 13,7 (2021): e16327. doi: https://doi.org/10.7759/cureus.16327
Khanduri S, Malik S, Khan N, Singh H, Rehman M. Beaver Tail Liver: A Hepatic Morphology Variant. Cureus. 2021 Jul 12;13(7):e16327. doi: 10.7759/cureus.16327. eCollection 2021 Jul. PMID: 34395114; PMCID: PMC8357019.
Copy Download .nbib Format: NLM
COVID-19 Infection Detection from Chest X-Ray Images Using Hybrid Social Group Optimization and Support Vector Classifier.

Cognitive computation

Singh AK, Kumar A, Mahmud M, Kaiser MS, Kishore A.
PMID: 33688379
Cognit Comput. 2021 Mar 04;1-13. doi: 10.1007/s12559-021-09848-3. Epub 2021 Mar 04.

A novel strain of Coronavirus, identified as the Severe Acute Respiratory Syndrome-2 (SARS-CoV-2), outbroke in December 2019 causing the novel Corona Virus Disease (COVID-19). Since its emergence, the virus has spread rapidly and has been declared a global pandemic....

Cite
Singh AK, Kumar A, Mahmud M, et al. COVID-19 Infection Detection from Chest X-Ray Images Using Hybrid Social Group Optimization and Support Vector Classifier. Cognit Comput. 2021;1-13doi: 10.1007/s12559-021-09848-3.
Singh, A. K., Kumar, A., Mahmud, M., Kaiser, M. S., & Kishore, A. (2021). COVID-19 Infection Detection from Chest X-Ray Images Using Hybrid Social Group Optimization and Support Vector Classifier. Cognitive computation, 1-13. https://doi.org/10.1007/s12559-021-09848-3
Singh, Asu Kumar, et al. "COVID-19 Infection Detection from Chest X-Ray Images Using Hybrid Social Group Optimization and Support Vector Classifier." Cognitive computation vol. (2021): 1-13. doi: https://doi.org/10.1007/s12559-021-09848-3
Singh AK, Kumar A, Mahmud M, Kaiser MS, Kishore A. COVID-19 Infection Detection from Chest X-Ray Images Using Hybrid Social Group Optimization and Support Vector Classifier. Cognit Comput. 2021 Mar 04;1-13. doi: 10.1007/s12559-021-09848-3. Epub 2021 Mar 04. PMID: 33688379; PMCID: PMC7931982.
Copy Download .nbib Format: NLM
Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.

Bioorganic chemistry

Gummidi L, Kerru N, Ebenezer O, Awolade P, Sanni O, Islam MS, Singh P.
PMID: 34332231
Bioorg Chem. 2021 Oct;115:105210. doi: 10.1016/j.bioorg.2021.105210. Epub 2021 Jul 26.

A simple and efficient protocol was developed to synthesize a new library of thiazolidine-4-one molecular hybrids (4a-n) via a one-pot multicomponent reaction involving 5-substituted phenyl-1,3,4-thiadiazol-2-amines, substituted benzaldehydes and 2-mercaptoacetic acid. The synthesized compounds were evaluated in vitro for their...

Cite
Gummidi L, Kerru N, Ebenezer O, et al. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition. Bioorg Chem. 2021;115:105210doi: 10.1016/j.bioorg.2021.105210.
Gummidi, L., Kerru, N., Ebenezer, O., Awolade, P., Sanni, O., Islam, M. S., & Singh, P. (2021). Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition. Bioorganic chemistry, 115105210. https://doi.org/10.1016/j.bioorg.2021.105210
Gummidi, Lalitha, et al. "Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition." Bioorganic chemistry vol. 115 (2021): 105210. doi: https://doi.org/10.1016/j.bioorg.2021.105210
Gummidi L, Kerru N, Ebenezer O, Awolade P, Sanni O, Islam MS, Singh P. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition. Bioorg Chem. 2021 Oct;115:105210. doi: 10.1016/j.bioorg.2021.105210. Epub 2021 Jul 26. PMID: 34332231.
Copy Download .nbib Format: NLM
Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial.

Indian journal of anaesthesia

Jindal S, Mittal A, Anand LK, Singh M, Kapoor D.
PMID: 33814586
Indian J Anaesth. 2021 Mar;65:S20-S26. doi: 10.4103/ija.IJA_1254_20. Epub 2021 Mar 20.

BACKGROUND AND AIMS: The Air-Q blocker (Cook gas LLC, Mercury Medical, Clearwater, FL, USA) is a relatively new supraglottic airway device (SAD) with capability to serve as a conduit for intubation. As there is limited data on Air-Q blocker,...

Cite
Jindal S, Mittal A, Anand LK, et al. Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial. Indian J Anaesth. 2021;65:S20-S26doi: 10.4103/ija.IJA_1254_20.
Jindal, S., Mittal, A., Anand, L. K., Singh, M., & Kapoor, D. (2021). Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial. Indian journal of anaesthesia, 65S20-S26. https://doi.org/10.4103/ija.IJA_1254_20
Jindal, Swati, et al. "Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial." Indian journal of anaesthesia vol. 65 (2021): S20-S26. doi: https://doi.org/10.4103/ija.IJA_1254_20
Jindal S, Mittal A, Anand LK, Singh M, Kapoor D. Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial. Indian J Anaesth. 2021 Mar;65:S20-S26. doi: 10.4103/ija.IJA_1254_20. Epub 2021 Mar 20. PMID: 33814586; PMCID: PMC7993039.
Copy Download .nbib Format: NLM
pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.

Current drug delivery

Agrawal V, Sandal N, Singh AK, Pathak DP.
PMID: 33504305
Curr Drug Deliv. 2021;18(8):1162-1173. doi: 10.2174/1567201818666210127093327.

BACKGROUND: Prussian Blue (PB) is available as conventional release dosage form "Radiogardase" with effective daily dose of 3-10 g (very high). The target site is the duodenum, where it inhibits the enterohepatic circulation of Cs & Tl ions, enhancing...

Cite
Agrawal V, Sandal N, Singh AK, et al. pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent. Curr Drug Deliv. 2021;18(8):1162-1173doi: 10.2174/1567201818666210127093327.
Agrawal, V., Sandal, N., Singh, A. K., & Pathak, D. P. (2021). pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent. Current drug delivery, 18(8), 1162-1173. https://doi.org/10.2174/1567201818666210127093327
Agrawal, Vaishali, et al. "pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent." Current drug delivery vol. 18,8 (2021): 1162-1173. doi: https://doi.org/10.2174/1567201818666210127093327
Agrawal V, Sandal N, Singh AK, Pathak DP. pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent. Curr Drug Deliv. 2021;18(8):1162-1173. doi: 10.2174/1567201818666210127093327. PMID: 33504305.
Copy Download .nbib Format: NLM
Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute.

Indian journal of surgical oncology

Rathod PS, Singh A, Punyashree RM, Pallavi VR, Usha A, Vijay CR, Shoba K, Rajshekar K.
PMID: 33814829
Indian J Surg Oncol. 2021 Mar;12(1):31-38. doi: 10.1007/s13193-020-01224-1. Epub 2020 Sep 23.

To study the clinical, biochemical, radiological, pathological characteristics, surgical treatment details, and follow-up of growing teratoma syndrome (GTS) patients. This is a retrospective study of GTS treated in the Department of Gynaecological Oncology at a regional cancer institute from...

Cite
Rathod PS, Singh A, Punyashree RM, et al. Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute. Indian J Surg Oncol. 2020;12(1):31-38doi: 10.1007/s13193-020-01224-1.
Rathod, P. S., Singh, A., Punyashree, R. M., Pallavi, V. R., Usha, A., Vijay, C. R., Shoba, K., & Rajshekar, K. (2021). Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute. Indian journal of surgical oncology, 12(1), 31-38. https://doi.org/10.1007/s13193-020-01224-1
Rathod, Praveen S, et al. "Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute." Indian journal of surgical oncology vol. 12,1 (2021): 31-38. doi: https://doi.org/10.1007/s13193-020-01224-1
Rathod PS, Singh A, Punyashree RM, Pallavi VR, Usha A, Vijay CR, Shoba K, Rajshekar K. Growing Teratoma Syndrome a Rare Clinical Entity: Two Decades Management Experience from the Regional Cancer Institute. Indian J Surg Oncol. 2021 Mar;12(1):31-38. doi: 10.1007/s13193-020-01224-1. Epub 2020 Sep 23. PMID: 33814829; PMCID: PMC7960805.
Copy Download .nbib Format: NLM
Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort.

Clinical lung cancer

Singh S, Pavesi F, Steiling K, Asokan S, Espinosa C, Cabral HJ, Burks EJ, Meister A, Akpoviroro O, Buck A, Drozdowicz K, Litle VR, Suzuki K.
PMID: 34393063
Clin Lung Cancer. 2021 Jul 19; doi: 10.1016/j.cllc.2021.07.009. Epub 2021 Jul 19.

INTRODUCTION/BACKGROUND: The USPSTF (United States Preventive Services Task Force) guidelines suggest criteria centering on smoking status and age to select patients for lung cancer screening. Despite the significant advances in screening with low-dose computed tomography (LDCT), cancer detection rate...

Cite
Singh S, Pavesi F, Steiling K, et al. Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort. Clin Lung Cancer. 2021;doi: 10.1016/j.cllc.2021.07.009.
Singh, S., Pavesi, F., Steiling, K., Asokan, S., Espinosa, C., Cabral, H. J., Burks, E. J., Meister, A., Akpoviroro, O., Buck, A., Drozdowicz, K., Litle, V. R., & Suzuki, K. (2021). Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort. Clinical lung cancer, . https://doi.org/10.1016/j.cllc.2021.07.009
Singh, Sarah, et al. "Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort." Clinical lung cancer vol. (2021). doi: https://doi.org/10.1016/j.cllc.2021.07.009
Singh S, Pavesi F, Steiling K, Asokan S, Espinosa C, Cabral HJ, Burks EJ, Meister A, Akpoviroro O, Buck A, Drozdowicz K, Litle VR, Suzuki K. Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort. Clin Lung Cancer. 2021 Jul 19; doi: 10.1016/j.cllc.2021.07.009. Epub 2021 Jul 19. PMID: 34393063.
Copy Download .nbib Format: NLM
The effect of age on fever response among nursing home residents with SARS-COV-2 infection.

Aging clinical and experimental research

Sachar M, Bayer T, DeVone F, Halladay C, McConeghy K, Elhamamsy S, Rajan A, Cadieux M, Singh M, Nanda A, Rudolph JL, McNicoll L, Cizginer S, Gravenstein S.
PMID: 35025096
Aging Clin Exp Res. 2022 Jan 13; doi: 10.1007/s40520-021-02048-x. Epub 2022 Jan 13.

Over 15,000 veterans in 135 VA nursing homes were systematically tested for SARS-CoV-2 and had daily temperatures assessed from March to August, 2020. Lower baseline temperatures, and in SARS-CoV-2+ , lower maximum temperatures were observed with advancing age. Clinicians...

Cite
Sachar M, Bayer T, DeVone F, et al. The effect of age on fever response among nursing home residents with SARS-COV-2 infection. Aging Clin Exp Res. 2022;doi: 10.1007/s40520-021-02048-x.
Sachar, M., Bayer, T., DeVone, F., Halladay, C., McConeghy, K., Elhamamsy, S., Rajan, A., Cadieux, M., Singh, M., Nanda, A., Rudolph, J. L., McNicoll, L., Cizginer, S., & Gravenstein, S. (2022). The effect of age on fever response among nursing home residents with SARS-COV-2 infection. Aging clinical and experimental research, . https://doi.org/10.1007/s40520-021-02048-x
Sachar, Moniyka, et al. "The effect of age on fever response among nursing home residents with SARS-COV-2 infection." Aging clinical and experimental research vol. (2022). doi: https://doi.org/10.1007/s40520-021-02048-x
Sachar M, Bayer T, DeVone F, Halladay C, McConeghy K, Elhamamsy S, Rajan A, Cadieux M, Singh M, Nanda A, Rudolph JL, McNicoll L, Cizginer S, Gravenstein S. The effect of age on fever response among nursing home residents with SARS-COV-2 infection. Aging Clin Exp Res. 2022 Jan 13; doi: 10.1007/s40520-021-02048-x. Epub 2022 Jan 13. PMID: 35025096.
Copy Download .nbib Format: NLM
Low-noise, high-detectivity, polarization-sensitive, room-temperature infrared photodetectors based on Ge quantum dot-decorated Si-on-insulator nanowire field-effect transistors.

Nanotechnology

John JW, Dhyani V, Singh S, Jakhar A, Sarkar A, Das S, Ray SK.
PMID: 33845466
Nanotechnology. 2021 May 10;32(31). doi: 10.1088/1361-6528/abf6f0.

A CMOS-compatible infrared (IR; 1200-1700 nm) detector based on Ge quantum dots (QDs) decorated on a single Si-nanowire channel on a silicon-on-insulator (SOI) platform with a superior detectivity at room temperature is presented. The spectral response of a single...

Cite
John JW, Dhyani V, Singh S, et al. Low-noise, high-detectivity, polarization-sensitive, room-temperature infrared photodetectors based on Ge quantum dot-decorated Si-on-insulator nanowire field-effect transistors. Nanotechnology. 2021;32(31)doi: 10.1088/1361-6528/abf6f0.
John, J. W., Dhyani, V., Singh, S., Jakhar, A., Sarkar, A., Das, S., & Ray, S. K. (2021). Low-noise, high-detectivity, polarization-sensitive, room-temperature infrared photodetectors based on Ge quantum dot-decorated Si-on-insulator nanowire field-effect transistors. Nanotechnology, 32(31), . https://doi.org/10.1088/1361-6528/abf6f0
John, John Wellington, et al. "Low-noise, high-detectivity, polarization-sensitive, room-temperature infrared photodetectors based on Ge quantum dot-decorated Si-on-insulator nanowire field-effect transistors." Nanotechnology vol. 32,31 (2021). doi: https://doi.org/10.1088/1361-6528/abf6f0
John JW, Dhyani V, Singh S, Jakhar A, Sarkar A, Das S, Ray SK. Low-noise, high-detectivity, polarization-sensitive, room-temperature infrared photodetectors based on Ge quantum dot-decorated Si-on-insulator nanowire field-effect transistors. Nanotechnology. 2021 May 10;32(31). doi: 10.1088/1361-6528/abf6f0. PMID: 33845466.
Copy Download .nbib Format: NLM
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model.

The Journal of clinical investigation

Sharan R, Ganatra SR, Bucsan AN, Cole J, Singh DK, Alvarez X, Gough M, Alvarez C, Blakley A, Ferdin J, Thippeshappa R, Singh B, Escobedo R, Shivanna V, Dick EJ, Hall-Ursone S, Khader SA, Mehra S, Rengarajan J, Kaushal D.
PMID: 34855621
J Clin Invest. 2021 Dec 02; doi: 10.1172/JCI153090. Epub 2021 Dec 02.

Studies using the nonhuman primate model of M. tuberculosis /Simian Immunodeficiency Virus co-infection have revealed protective CD4+ T cell-independent immune responses that suppress LTBI reactivation. In particular, chronic immune activation rather than the mere depletion of CD4+ T cells...

Cite
Sharan R, Ganatra SR, Bucsan AN, et al. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model. J Clin Invest. 2021;doi: 10.1172/JCI153090.
Sharan, R., Ganatra, S. R., Bucsan, A. N., Cole, J., Singh, D. K., Alvarez, X., Gough, M., Alvarez, C., Blakley, A., Ferdin, J., Thippeshappa, R., Singh, B., Escobedo, R., Shivanna, V., Dick, E. J., Hall-Ursone, S., Khader, S. A., Mehra, S., Rengarajan, J., & Kaushal, D. (2021). Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model. The Journal of clinical investigation, . https://doi.org/10.1172/JCI153090
Sharan, Riti, et al. "Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model." The Journal of clinical investigation vol. (2021). doi: https://doi.org/10.1172/JCI153090
Sharan R, Ganatra SR, Bucsan AN, Cole J, Singh DK, Alvarez X, Gough M, Alvarez C, Blakley A, Ferdin J, Thippeshappa R, Singh B, Escobedo R, Shivanna V, Dick EJ, Hall-Ursone S, Khader SA, Mehra S, Rengarajan J, Kaushal D. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model. J Clin Invest. 2021 Dec 02; doi: 10.1172/JCI153090. Epub 2021 Dec 02. PMID: 34855621.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 25833 entries